Presented by Whitney Clausen, RRT, BSRT, MS, Director of Cardiopulmonary Services, and Mark Greenwood, BSRC, RRT-ACCS, Respiratory Clinical Manager.
Lung cancer is the leading cause of cancer deaths worldwide. In the U.S., the average five-year survival rate for all stages of non-small cell lung cancer (the most common kind) is 23%. Early detection can significantly improve outcomes. More than 70% of all lung cancer nodules are in the outer one-third of the lung, an area full of tight spaces and narrow airways that may be hard to reach. Physicians now have a better, more innovative approach to reach these spaces for earlier detection, and possibly diagnosis and treatment, of lung cancer by utilizing a minimally invasive robotic-assisted platform, called ION Navigational Bronchoscopy.
